Susan L Orrill

Title: The Innovative Contributions of Susan L. Orrill

Introduction

Susan L. Orrill is a notable inventor based in Gales Ferry, Connecticut. She has made significant contributions to the field of pharmaceuticals, particularly in the development of glycogen phosphorylase inhibitors. With a total of 2 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Orrill's latest patents include "Processes and intermediates for preparing glycogen phosphorylase inhibitors." This invention provides novel processes and intermediates useful in the preparation of certain N-(indole-2-carbonyl)-β-alaninamide compounds. These compounds are glycogen phosphorylase inhibitors that can be beneficial in treating diseases such as hypercholesterolemia, hyperglycemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis, diabetes, diabetic cardiomyopathy, infection, tissue ischemia, myocardial ischemia, and in inhibiting tumor growth. Another patent she holds is for "N-(indole-2-carbonyl)-β-alaninamide crystal forms," which further enhances her contributions to this important area of research.

Career Highlights

Susan L. Orrill is currently associated with Pfizer Corporation, a leading global pharmaceutical company. Her work at Pfizer has allowed her to focus on innovative solutions that address critical health issues.

Collaborations

Throughout her career, Orrill has collaborated with esteemed colleagues, including Frank R. Busch and Peter Robert Rose. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Susan L. Orrill's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a significant inventor. Her work continues to pave the way for advancements in the treatment of various diseases.